$PETS
PETMED EXPRESS INC

2020 Q1 Form 10-K Financial Statement

#000143774921013213 Filed on May 25, 2021

View on sec.gov

Income Statement

Concept 2020 Q1 2019 Q4 2019 Q3
Revenue $74.29M $59.92M $69.94M
YoY Change 15.06% -0.25% -2.04%
Cost Of Revenue $52.60M $42.22M $49.93M
YoY Change 19.98% 3.76% 8.22%
Gross Profit $21.69M $17.70M $20.00M
YoY Change 4.64% -8.69% -20.8%
Gross Profit Margin 29.19% 29.54% 28.6%
Selling, General & Admin $12.62M $9.200M $11.06M
YoY Change 2.1% -2.23% -3.83%
% of Gross Profit 58.19% 51.99% 55.29%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $560.0K $562.0K $572.0K
YoY Change -1.75% 1.08% 3.62%
% of Gross Profit 2.58% 3.18% 2.86%
Operating Expenses $13.17M $9.765M $11.63M
YoY Change 1.93% -2.04% -3.49%
Operating Profit $8.513M $7.932M $8.371M
YoY Change 9.11% -15.73% -36.6%
Interest Expense $300.0K $420.0K $460.0K
YoY Change -45.45% -17.65% 6.98%
% of Operating Profit 3.52% 5.3% 5.5%
Other Income/Expense, Net $310.0K $722.0K $763.0K
YoY Change 19.23% -5.37% 11.71%
Pretax Income $9.120M $8.654M $9.134M
YoY Change 5.92% -14.96% -34.22%
Income Tax $2.120M $1.800M $2.469M
% Of Pretax Income 23.25% 20.8% 27.03%
Net Earnings $7.003M $6.840M $6.665M
YoY Change 5.79% -12.16% -38.01%
Net Earnings / Revenue 9.43% 11.42% 9.53%
Basic Earnings Per Share $0.34 $0.33
Diluted Earnings Per Share $0.35 $0.34 $0.33
COMMON SHARES
Basic Shares Outstanding 20.17M 19.98M 19.96M
Diluted Shares Outstanding 19.99M 19.97M

Balance Sheet

Concept 2020 Q1 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $103.8M $92.40M $94.90M
YoY Change 3.28% -0.86% 8.96%
Cash & Equivalents $103.8M $92.37M $94.90M
Short-Term Investments
Other Short-Term Assets $3.500M $4.200M $2.800M
YoY Change 150.0% 223.08% 180.0%
Inventory $17.90M $24.20M $19.10M
Prepaid Expenses
Receivables $3.843M $2.052M $1.466M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $129.0M $122.8M $118.3M
YoY Change 2.05% -4.44% -0.72%
LONG-TERM ASSETS
Property, Plant & Equipment $25.45M $25.92M $26.41M
YoY Change -6.23% -6.04% -5.95%
Goodwill
YoY Change
Intangibles $860.0K $860.0K $860.0K
YoY Change 0.0% 0.0% 0.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $26.31M $26.78M $27.27M
YoY Change -6.04% -5.86% -5.77%
TOTAL ASSETS
Total Short-Term Assets $129.0M $122.8M $118.3M
Total Long-Term Assets $26.31M $26.78M $27.27M
Total Assets $155.3M $149.5M $145.5M
YoY Change 0.58% -4.7% -1.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $19.66M $16.64M $15.16M
YoY Change 20.79% -17.99% 6.14%
Accrued Expenses $4.200M $3.200M $2.900M
YoY Change 75.0% 14.29% 3.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $24.34M $20.73M $18.55M
YoY Change 30.69% -10.09% 8.84%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $24.34M $20.73M $18.55M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $25.31M $21.83M $19.95M
YoY Change 28.19% -9.25% 9.41%
SHAREHOLDERS EQUITY
Retained Earnings $126.2M $124.6M $123.2M
YoY Change 3.28% 2.88% 3.6%
Common Stock $20.00K $20.00K $20.00K
YoY Change -4.76% -4.76% -4.76%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $130.0M $127.7M $125.6M
YoY Change
Total Liabilities & Shareholders Equity $155.3M $149.5M $145.5M
YoY Change 0.58% -4.7% -1.71%

Cashflow Statement

Concept 2020 Q1 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income $7.003M $6.840M $6.665M
YoY Change 5.79% -12.16% -38.01%
Depreciation, Depletion And Amortization $560.0K $562.0K $572.0K
YoY Change -1.75% 1.08% 3.62%
Cash From Operating Activities $17.26M $4.290M $17.25M
YoY Change 31.66% -63.11% -1158.28%
INVESTING ACTIVITIES
Capital Expenditures -$480.0K -$1.410M -$230.0K
YoY Change 336.36% 2250.0% 64.29%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$480.0K -$1.410M -$230.0K
YoY Change 336.36% 2250.0% 64.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.390M -5.400M -5.530M
YoY Change -4.43% -2.35% -2.3%
NET CHANGE
Cash From Operating Activities 17.26M 4.290M 17.25M
Cash From Investing Activities -480.0K -1.410M -230.0K
Cash From Financing Activities -5.390M -5.400M -5.530M
Net Change In Cash 11.39M -2.520M 11.49M
YoY Change 54.76% -141.72% -254.64%
FREE CASH FLOW
Cash From Operating Activities $17.26M $4.290M $17.25M
Capital Expenditures -$480.0K -$1.410M -$230.0K
Free Cash Flow $17.74M $5.700M $17.48M
YoY Change 34.19% -51.24% -1273.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20269313
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
39000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
59000 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
3000
CY2020Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
3000
CY2021Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2020Q1 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20269000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20269000
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20166000
CY2020Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20166000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY1998Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2010Q4 pets Stock Repurchase Program Additional Authorized Amount
StockRepurchaseProgramAdditionalAuthorizedAmount
20000000.0 USD
CY2011Q3 pets Stock Repurchase Program Additional Authorized Amount
StockRepurchaseProgramAdditionalAuthorizedAmount
20000000.0 USD
CY2021 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2020 us-gaap Deferred Compensation Arrangement With Individual Requisite Service Period1
DeferredCompensationArrangementWithIndividualRequisiteServicePeriod1
P1Y
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
118718000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
103762000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2587000 USD
CY2020Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3843000 USD
CY2021Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
34420000 USD
CY2020Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
17884000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4503000 USD
CY2020Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3529000 USD
CY2021Q1 us-gaap Prepaid Taxes
PrepaidTaxes
959000 USD
CY2020Q1 us-gaap Prepaid Taxes
PrepaidTaxes
0 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
161187000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
129018000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25450000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25445000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
860000 USD
CY2021Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
26310000 USD
CY2020Q1 us-gaap Assets Noncurrent
AssetsNoncurrent
26305000 USD
CY2021Q1 us-gaap Assets
Assets
187497000 USD
CY2020Q1 us-gaap Assets
Assets
155323000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
39548000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
19658000 USD
CY2021Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5387000 USD
CY2020Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4214000 USD
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 USD
CY2020Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
471000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
44935000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
24343000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1281000 USD
CY2020Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
970000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
46216000 USD
CY2020Q1 us-gaap Liabilities
Liabilities
25313000 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
9000 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
9000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
20000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7111000 USD
CY2020Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3804000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
134141000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
126177000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
141281000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
130010000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
187497000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
155323000 USD
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
309215000 USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
284125000 USD
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
283419000 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
219267000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
202879000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
188105000 USD
CY2021 us-gaap Gross Profit
GrossProfit
89948000 USD
CY2020 us-gaap Gross Profit
GrossProfit
81246000 USD
CY2019 us-gaap Gross Profit
GrossProfit
95314000 USD
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28293000 USD
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25264000 USD
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24767000 USD
CY2021 us-gaap Advertising Expense
AdvertisingExpense
21641000 USD
CY2020 us-gaap Advertising Expense
AdvertisingExpense
22748000 USD
CY2019 us-gaap Advertising Expense
AdvertisingExpense
22148000 USD
CY2021 us-gaap Depreciation
Depreciation
2427000 USD
CY2020 us-gaap Depreciation
Depreciation
2257000 USD
CY2019 us-gaap Depreciation
Depreciation
2225000 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
52361000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
50269000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
49140000 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
37587000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
30977000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
46174000 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
314000 USD
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
1747000 USD
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
1864000 USD
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1315000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1169000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1083000 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1629000 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2916000 USD
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2947000 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
39216000 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
33893000 USD
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
49121000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8613000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8042000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11381000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
30603000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
25851000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
37740000 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.84
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.29
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.84
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20060000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20041000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20461000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20119000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20055000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20491000
CY2021 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.12
CY2020 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.08
CY2019 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.06
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
115731000 USD
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3097000 USD
CY2019 us-gaap Dividends Common Stock
DividendsCommonStock
21888000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
37740000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
134680000 USD
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2822000 USD
CY2020 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11497000 USD
CY2020 us-gaap Dividends Common Stock
DividendsCommonStock
21846000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
25851000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
130010000 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3307000 USD
CY2021 us-gaap Dividends Common Stock
DividendsCommonStock
22639000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
30603000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
141281000 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
30603000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
25851000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
37740000 USD
CY2021 us-gaap Depreciation
Depreciation
2427000 USD
CY2020 us-gaap Depreciation
Depreciation
2257000 USD
CY2019 us-gaap Depreciation
Depreciation
2225000 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
3307000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2822000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3097000 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
311000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-151000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
125000 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
130000 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
191000 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
85000 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1126000 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1492000 USD
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
335000 USD
CY2021 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
16536000 USD
CY2020 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-3486000 USD
CY2019 us-gaap Increase Decrease In Finished Goods And Work In Process Inventories
IncreaseDecreaseInFinishedGoodsAndWorkInProcessInventories
-1967000 USD
CY2021 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
959000 USD
CY2020 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-582000 USD
CY2019 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-206000 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
974000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
376000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
526000 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
19890000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3383000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1001000 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1221000 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1820000 USD
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-447000 USD
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-471000 USD
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
471000 USD
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
40075000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38844000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
45138000 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2432000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2311000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
620000 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2432000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2311000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-620000 USD
CY2021 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
22687000 USD
CY2020 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21803000 USD
CY2019 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
21925000 USD
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
11497000 USD
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22687000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-33300000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21925000 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14956000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3233000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
22593000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
103762000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
100529000 USD
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
77936000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
118718000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
103762000 USD
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
100529000 USD
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
10018000 USD
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
7140000 USD
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
11051000 USD
CY2021 pets Transfer Of Property And Equipment To Current Assets
TransferOfPropertyAndEquipmentToCurrentAssets
0 USD
CY2020 pets Transfer Of Property And Equipment To Current Assets
TransferOfPropertyAndEquipmentToCurrentAssets
1745000 USD
CY2019 pets Transfer Of Property And Equipment To Current Assets
TransferOfPropertyAndEquipmentToCurrentAssets
0 USD
CY2021 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
198000 USD
CY2020 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
246000 USD
CY2019 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
203000 USD
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
309215000 USD
CY2021 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
284125000 USD
CY2020 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2021 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
25090000 USD
CY2021 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.088 pure
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
309215000 USD
CY2021 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
284125000 USD
CY2020 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2021 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
25090000 USD
CY2021 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.088 pure
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
284125000 USD
CY2020 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
283419000 USD
CY2019 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
706000 USD
CY2020 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.002 pure
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
284125000 USD
CY2020 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
283419000 USD
CY2019 pets Revenue From Contract With Customer Percentage
RevenueFromContractWithCustomerPercentage
1.000 pure
CY2020 pets Revenue From Contract With Customer Variance
RevenueFromContractWithCustomerVariance
706000 USD
CY2020 pets Revenue From Contract With Customer Variance Percentage
RevenueFromContractWithCustomerVariancePercentage
0.002 pure
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
39000 USD
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
59000 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;"><b>Use of Estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
86000 USD
CY2020Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
45000 USD
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>Business Concentrations</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">The Company purchases its products from a variety of sources, including certain manufacturers, domestic distributors, and wholesalers. We have multiple suppliers for each of our products to obtain the lowest cost. There were five suppliers from whom we purchased approximately 80% of all products in fiscal <em style="font: inherit;">2021.</em> There were three suppliers from whom we purchased approximately 60% of all products in fiscal <em style="font: inherit;">2020.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
35778000 USD
CY2020Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36099000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10328000 USD
CY2020Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10654000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25450000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25445000 USD
CY2020Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
59000 USD
CY2019Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
39000 USD
CY2018Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
35000 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
130000 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
191000 USD
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
85000 USD
CY2021 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
150000 USD
CY2020 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
171000 USD
CY2019 us-gaap Valuation Allowances And Reserves Deductions
ValuationAllowancesAndReservesDeductions
81000 USD
CY2021Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
39000 USD
CY2020Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
59000 USD
CY2019Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
39000 USD
CY2021Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1063000 USD
CY2020Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
627000 USD
CY2021Q1 pets Accrued Credit Card Fees Current
AccruedCreditCardFeesCurrent
456000 USD
CY2020Q1 pets Accrued Credit Card Fees Current
AccruedCreditCardFeesCurrent
494000 USD
CY2021Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1525000 USD
CY2020Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
1242000 USD
CY2021Q1 pets Accrued Merchandise Credits And Rewards Current
AccruedMerchandiseCreditsAndRewardsCurrent
1413000 USD
CY2020Q1 pets Accrued Merchandise Credits And Rewards Current
AccruedMerchandiseCreditsAndRewardsCurrent
674000 USD
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
290000 USD
CY2020Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
267000 USD
CY2021Q1 pets Accrued Sales Returns And Allowances Current
AccruedSalesReturnsAndAllowancesCurrent
220000 USD
CY2020Q1 pets Accrued Sales Returns And Allowances Current
AccruedSalesReturnsAndAllowancesCurrent
244000 USD
CY2021Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
198000 USD
CY2020Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
246000 USD
CY2021Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
114000 USD
CY2020Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current And Noncurrent
AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent
112000 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
108000 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
308000 USD
CY2021Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
5387000 USD
CY2020Q1 pets Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
4214000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
406000 USD
CY2020Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
287000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
321000 USD
CY2020Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
469000 USD
CY2021Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
29000 USD
CY2020Q1 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
24000 USD
CY2021Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
756000 USD
CY2020Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
780000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2037000 USD
CY2020Q1 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1750000 USD
CY2021Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1281000 USD
CY2020Q1 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
970000 USD
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
7446000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
7352000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
9718000 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
856000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
841000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1538000 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8302000 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
8193000 USD
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
11256000 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
279000 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-135000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
108000 USD
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
32000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-16000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
17000 USD
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
311000 USD
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-151000 USD
CY2019 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
125000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8613000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8042000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11381000 USD
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
8235000 USD
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
7118000 USD
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
10315000 USD
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
708000 USD
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
649000 USD
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
1233000 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-135000 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
322000 USD
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-176000 USD
CY2021 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-195000 USD
CY2020 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
-47000 USD
CY2019 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
9000 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8613000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8042000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11381000 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-135000 USD
CY2021 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-194000 USD
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
322000 USD
CY2020 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
-93000 USD
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-176000 USD
CY2019 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
8000 USD
CY1998Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
250000
CY1998Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
4.00
CY1998Q2 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
112187 USD
CY1998Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
4.05
CY1998Q2 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
4.00
CY2006Q4 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
20000000.0 USD
CY2008Q4 pets Stock Repurchase Program Additional Authorized Amount
StockRepurchaseProgramAdditionalAuthorizedAmount
20000000.0 USD
CY2019Q1 pets Stock Repurchase Program Additional Authorized Amount
StockRepurchaseProgramAdditionalAuthorizedAmount
30000000.0 USD
CY2020 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
613000
CY2020 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
11500000 USD
CY2019 us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2021Q1 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
28700000 USD
CY2018Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.27
CY2020Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.28
CY2012Q3 pets Percentage Of Automatic Increase In Shares Available For Issuance
PercentageOfAutomaticIncreaseInSharesAvailableForIssuance
0.10 pure
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
3300000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2800000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
3100000 USD
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
183000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
106000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
126000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
3000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
160000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
30603000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
25851000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
5343000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
6665000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
6840000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
7003000 USD
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.26
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.33
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2019 us-gaap Net Income Loss
NetIncomeLoss
37740000 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20060000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20041000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20461000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
49000
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4000
CY2019 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
20000
CY2021 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2020 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2019 us-gaap Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
10000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20119000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20055000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20491000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.29
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.84
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.29
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.84
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20952
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
72120
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
126751
CY2020 pets Defined Contribution Plan With Individual Age
DefinedContributionPlanWithIndividualAge
P21Y
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
245000 USD
CY2020 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
211000 USD
CY2019 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
192000 USD
CY2021Q1 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.28
CY2020Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
96204000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
75436000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
65896000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
71679000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
26785000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
23018000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
19623000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
20522000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
9436000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
10471000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
9293000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8387000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
7768000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
8412000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
7611000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
6812000 USD
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.39
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.34
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
79988000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
69936000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
59915000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
74286000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
21861000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
20002000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
17697000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
21686000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
6161000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8371000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
7932000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8513000 USD

Files In Submission

Name View Source Status
0001437749-21-013213-index-headers.html Edgar Link pending
0001437749-21-013213-index.html Edgar Link pending
0001437749-21-013213.txt Edgar Link pending
0001437749-21-013213-xbrl.zip Edgar Link pending
chart01.jpg Edgar Link pending
ex_252271.htm Edgar Link pending
ex_252272.htm Edgar Link pending
ex_252273.htm Edgar Link pending
ex_252274.htm Edgar Link pending
ex_252275.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pets-20210331.xsd Edgar Link pending
pets-20210331_cal.xml Edgar Link unprocessable
pets-20210331_def.xml Edgar Link unprocessable
pets-20210331_lab.xml Edgar Link unprocessable
pets-20210331_pre.xml Edgar Link unprocessable
pets20210331_10k.htm Edgar Link pending
pets20210331_10k_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending